PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.310
+0.030 (2.34%)
At close: Apr 17, 2026, 4:00 PM EDT
1.319
+0.009 (0.71%)
After-hours: Apr 17, 2026, 7:42 PM EDT
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $73.12 million as of April 17, 2026. Its market cap has increased by 39.45% in one year.
Market Cap
73.12M
Enterprise Value
63.33M
1-Year Change
39.45%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has increased from $45.51M to $73.12M, an increase of 60.65%. That is a compound annual growth rate of 6.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 73.12M | 73.58% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortress Biotech | 76.00M |
| XBiotech | 75.00M |
| PMV Pharmaceuticals | 73.59M |
| Immutep | 73.10M |
| ImmuCell | 72.19M |
| MediciNova | 71.86M |
| TScan Therapeutics | 71.52M |
| Grace Therapeutics | 71.18M |